Candriam SCA’s Encompass Health EHC Stock Holding History

Candriam SCA’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.87M	Sell	68,000 -1,375	-2%	-$142K	0.03%	342
2026 Q1	$6.71M	Buy	+69,375	New	+$7.11M	0.03%	345
2024 Q4	–	Sell	-82,974	Closed	-$8.02M	–	681
2024 Q3	$8.02M	Buy	82,974 +20,948	+34%	+$1.88M	0.05%	295
2024 Q2	$5.32M	Sell	62,026 -2,958	-5%	-$248K	0.03%	331
2024 Q1	$5.37M	Buy	64,984 +2,304	+4%	+$169K	0.03%	329
2023 Q4	$4.18M	Buy	62,680 +6,680	+12%	+$433K	0.03%	357
2023 Q3	$3.76M	Hold	56,000	–	–	0.03%	341
2023 Q2	$3.79M	Buy	56,000 +47,365	+549%	+$2.97M	0.03%	378
2023 Q1	$430K	Sell	8,635 -7,025	-45%	-$409K	﹤0.01%	803
2022 Q4	$937K	Sell	15,660 -4,247	-21%	-$231K	0.01%	706
2022 Q3	$900K	Buy	+19,907	New	+$996K	0.01%	729

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Candriam SCA's EHC Position: Q2 2026 in Review

Candriam SCA reduced its Encompass Health (EHC) stake by 2% in Q2 2026, selling an estimated $142K and leaving 68,000 shares worth $6.87M. The position accounts for 0.03% of the portfolio, ranked #342.

Candriam SCA first reported a position in EHC in Q3 2022 and has held it in 11 quarters since. The position peaked at $8.02M in Q3 2024. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

Candriam SCA held 68,000 shares of Encompass Health worth $6.87M as of Q2 2026.
Candriam SCA sold 1,375 Encompass Health shares in Q2 2026, an estimated $142K.
Encompass Health made up 0.03% of Candriam SCA's portfolio in Q2 2026, its #342 holding.
Candriam SCA first reported a position in Encompass Health in Q3 2022 and has held it in 11 quarters since.
Candriam SCA's Encompass Health position peaked at $8.02M in Q3 2024.
599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.